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Aim.InthisstudywereportourexperiencewithmicrohematuriaanditsrelationwithbladdertumorsinIranianwomen.Materials
and Methods. Overall 249 women were evaluated. Microscopic hematuria was deﬁned as three or more red blood cells per high-
p o w e rﬁ e l do na tl e a s tt w od i ﬀerent occasions. Patients with a history of gross hematuria or coagulation disorders, having organic
diseases, urinary stones, urinary tract infections, nephrological diseases, and local lesions such as urethral caruncle were excluded
from the study population. Final diagnosis of malignant tumors was done with cystoscopy and biopsy specimen pathological
assessment in all cases. Results. Age for the study population was 49.7 ± 11.8 years. 95 (38%) of patients were identiﬁed during
routine check up and presenting symptoms in other patients were frequency, dysuria, stress urge incontinence, urge incontinence,
feeling of incomplete urine emptying, and ﬂunk pain, respectively. Finally, 7 (2.8%) of study subjects were conﬁrmed as having
bladder tumors. One of tumor cases was diagnosed 24 months after initial assessments. Patients with bladder tumor were
signiﬁcantly older; more frequently had diverticulum in their bladder wall (P<. 05). Conclusion. Female microscopic hematuria is
relevant and deserves evaluations, especially in elderly patients. Patients whosereason for microhematuria would not be diagnosed
at the initial evaluations should be followed.
Copyright © 2009 Shahin Abbaszadeh et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Microscopic hematuria is a common clinical problem with
a prevalence of 0.18 to 21 percent in adults [1–5]. This
widerangereﬂectsthediﬀeringcriteriafordeﬁningclinically
signiﬁcant haematuria, and the varying ages of the study
population. Urine normally contains a few red blood cells
and microscopic hematuria is generally deﬁned as three or
moreredbloodcellsperhighpowerﬁeld(HPF),fromatleast
two properly collected urinalysis specimens [6, 7].
Microscopic hematuria may be transient. It may occur
in up to 13% of postmenopausal women [8]. Transient
microscopic hematuria in women may be caused by sexual
intercourse, by menstrual contamination, or even by mild
trauma. Microscopic hematuria, unlike gross hematuria, is
often an incidental ﬁnding, but may be associated with
serious conditions. The many causes range from insignif-
icant lesions (caused by, e.g., vigorous exercise) to highly
signiﬁcant life-threatening lesions (e.g., urologic malignancy
in up to 10% of adults) [9].
Microscopic hematuria in women may be of lesser
relevance than in men [6] but, there is still need for further
evaluations in women with microscopic hematuria [10–
12]. Diﬀerent incidences of bladder tumors among women
with microhematuria have been reported from diﬀerent
countries. In this study, we aimed to assess the incidence of
bladder tumor among Iranian women undergoing investiga-
tion for microscopic hematuria.
2. Methods andPatients
2.1. Patients. Microscopic hematuria was deﬁned as three or
more red blood cells per high-power ﬁeld on at least two
diﬀerent occasions, with a minimum time gap of at least two
weeks between. We included all 249 female patients, without2 Advances in Urology
a previous history for urologic problems, who were detected
incidentally at our outpatient clinic or were referred to our
clinic for the evaluation of microscopic hematuria, from
February 2003 through March 2007. All referred patients
were reevaluated for conﬁrmation of having hematuria.
Urine cytology was performed in a number of patients
(depending on physician’s decision with no deﬁnite criteria)
toevaluatewhetheraneoplasticprocesswasthesourceofthe
hematuria before any radiological or urologic procedures;
mid-stream urine samples were collected, immediately pro-
cessed, and subsequently examined cytologically. Urinalysis
and urine culture were performed on all patients. Patients
with a history of gross hematuria or coagulation disor-
ders, having organic diseases, urinary stones, urinary tract
infections, nephrological diseases, and local lesions such as
urethral caruncle were excluded from the study population.
Renal ultrasonography and cystoscopy were performed
on all patients. If the patients had persistent hematuria with
no deﬁnitive diagnosis, Intravenous urography (IVU) was
performed.
Before cystoscopy, vaginal and urethral examinations
were performed in all patients to exclude local causes of
microscopic hematuria. Rigid cystoscopy was done under
local anesthesia. At cystoscopy urethra, urethral oriﬁce and
systematic evaluation of the entire bladder surface was
performed. Cystoscopy was done by using the 30 and 70
degree lens. After complete inspection of the urethra and
bladder has been accomplished, the bladder is drained and
the instrument is gently removed. Biopsy was performed
if suspicious lesions were seen or if (+) cytology was
obtained.Finaldiagnosisofmalignanttumorswasdonewith
cystoscopy and biopsy specimen pathological assessment in
all cases.
2.2. Statistical Analysis. Data are shown as mean ± SD.
Pearson Chi-square test and student’s t-test were used for
evaluations where appropriate. Non-parametric evaluations
by Chi-square and Mann-Whitney U-tests were also per-
formed for conﬁrmation; non parametric evaluations did
not change initial ﬁndings. Because of the limited number
of patients included into this study, we were unable to
make multivariate analyses. Two-tailed P values ≤ .05 were
considered signiﬁcant.
3. Results
Age for the study population was 49.7 ± 11.8 years (range
30–85). 95 (38%) of patients were identiﬁed during routine
check up; presenting symptoms in the remaining 154
(61.8%) patients were frequency 61 (24.5%), dysuria 51
(20.5%), stress urge incontinence 39 (15.7%), urge inconti-
nence 24 (9.6%), feeling of incomplete urine emptying 23
(9.2%), and ﬂunk pain 7 (2.8%). On ultrasonography, 12
(4.8%) had large urinary residual volumes.
Cystoscopic evaluations revealed 10 patients with ure-
thral stricture, 83 (33%) with mild to moderate and 3 (1.2%)
with severe bladder wall trabeculation. Three (1.2%) also
had bladder wall diverticulum. Overall, 7 (2.8%) patients
were diagnosed as having bladder tumor. The characteristics
of these patients are summarized in Table 1. Patients with
bladder tumor were signiﬁcantly older than others (67.6
± 12.2 versus 49.1 ± 11.4 years old, resp. P<. 0001).
There was no diﬀerence between two groups (with and
without malignancy) regarding their presenting symptoms.
Patients with bladder tumor had signiﬁcantly higher rate of
diverticulum (P = .001).
4. Discussion
In our study, we found a 2.8% bladder tumors frequency
among our Iranian females evaluated for microhematuria.
Other similar studies have shown both higher and lower
rates. No cases of bladder cancer were found in one prospec-
tive, referral-based study involving 177 American women
(mean age, 57.2 years) with asymptomatic microscopic
hematuria who underwent cystoscopy [13]. In a similar
study, involving 1034 Japanese adults (75% female), only
two cases of bladder cancer was identiﬁed in women with
microscopic hematuria [14]. Another study conducted in
the UK revealed an incidence of 1.4% of bladder tumors
in patients with microhematuria [15]. On the other hand,
some other studies have also reported high incidences of
malignancy among patients with microscopic hematuria.
In a study on 100 Bengali patients undergoing evaluations
for microscopic hematuria, an astonishing incidence of
16 (16%) malignancy (bladder tumor in 10 (10%)) was
observed[16].InareportfromtheUK,51outof982patients
(5.2%) presenting with microhematuria were diagnosed
as having cancer [17]. A Swedish study on patients with
hematuria demonstrated an incidence of 9% malignancies;
5% when asymptomatic [18].
The reasons behind these disparities may vary substan-
tially. Higher incidence of bladder cancer in speciﬁc ethnic
groupsmayberelatedtodiﬀerentcausesfromgeneticfactors
to particular lifestyle speciﬁcities such as food habits and
cigarette use. On the other hand, some interventional factors
may also confuse study results. Diﬀerent characteristics of
the study subjects in terms of age and gender and use
of diﬀerent inclusion criteria and diﬀerent study designs
(e.g., prospective, longitudinal, and retrospective and/or
population based versus referral based studies) can play
signiﬁcant roles in the study end results. There have been
onlyafewpopulation-basedstudiesaddressingtheincidence
of microscopic hematuria. Some studies suggest that there
may be an increased incidence among older persons, some
others show no diﬀerence according to age [8] and two
studies reported a higher incidence among women than
among men [10].
In our study, the incidence of malignancy was strongly
associated with patients’ age (P<. 0001). Previous studies
also strongly corroborate this ﬁnding. No female under 70
years and no male under 45 years of age with microscopic
hematuria was found to have malignant bladder tumors,
in a study by Boman et al. in Sweden [18]. An American
study assessing incidence of malignancy among individuals
withmicrohematuriaalsoreported thatnoneofwomenwithAdvances in Urology 3
Table 1: Characteristics of patients with conﬁrmed diagnosis of bladder tumor.
Patients Presenting symptoms Age Ultrasonography Tumor-stage Grade Other ﬁndings
Case 1 Check up 49 Single tumor on the
lateral bladder wall TCC-T1 Grade I
Cystoscopy: tumor on the right
lateral bladder wall, superior to
ureteral oriﬁce; size: 1∗2cm
Case 2 Right ﬂunk pain 70
Thickening of the
bladder wall, single
tumor
TCC-Ta Grade III
IVU: diverticulum inside the right
lateral bladder wall; size: 3∗2cm
Cystoscopy: tumor inside the
diverticulum, superior to right
ureteral oriﬁce
Case 3 Suprapubic pain and
frequency
78 3 ∗ papillary tumors
TCC (diagnosed 24
months after initial
evaluations)-Ta
Grade II
C y s t o s c o p y :m i l db l a d d e r
trabeculation and inﬂammation
and 3 Tumors, two on left bladder
wall superior to the ureteral oriﬁce
and one on the ﬂoor of bladder;
sizes: 1∗1&1 ∗0.5 & 1∗2cm
Cytology: negative for tumor (3
times during 24 months)
Case 4 Disuria 60 Single papillary
tumor TCC-T1 grade II
Cystoscopy: tumor on the right
lateral bladder wall, superior to
ureteral oriﬁce; size: 2∗3cm
Case 5
Disuria, urinary
frequency, urge
incontinence, stress
urge incontinence
70 Single tumor TCC-T1 grade II Cystoscopy: tumor on the left
bladder wall; size: 2∗2cm
Case 6 Disuria and frequency 68 Single tumor TCC-T1 Grade I Cystoscopy: tumor on anterior
bladder wall; size: 2∗2cm
Case 7 Disuria, frequency,
urge incontinence
85 Single tumor TCC-Ta grade I Cystoscopy: Tumor on the right
lateral bladder wall; size: 2∗2cm
cancer were below 65 years (versus 3/11 men) [19]. However,
in our study, 2 out of 7 cases of bladder tumor were below 65
years of age and the youngest case was 49 years old (Table 1).
Genderplaysasigniﬁcantroleintheincidenceofbladder
t u m o r s .M o s tp r e v i o u ss t u d i e sh a v ed e m o n s t r a t e dah i g h e r
incidence of bladder tumor among males with a reported
male to female ratio of 2.7:1[ 18–20]. Jaﬀee ta l .r e p o r t e d
that 3 women out of 62 (4.8% versus 11 (11.2%) men out
of 98) with microhematuria who underwent cystoscopy and
ultrasonography represented bladder cancer [19]. Boman
et al. also found that the incidence of malignancies was
strongly sex-related and occurs predominately in males [18].
According to these ﬁndings, some authors declared that
microscopic hematuria in females is of lesser relevance than
in men [6], especially when the women are under 65;
however, our study, with a 2.8% frequency of bladder tumor
detection in women with microhematuria, of whom about
29% were below 65 years of age, suggests that women with
microscopic hematuria, even under 65 years of age, should
also receive full evaluations.
The initial determination of microscopic hematuria
should be based on microscopic examination of urinary
sedimentfromafreshlyvoided,clean-catchmidstreamurine
specimen [21]. The recommended deﬁnition of microscopic
hematuria is three or more red blood cells per (HPF)
on microscopic evaluation of urinary sediment from two
of three properly collected urinalysis specimen [17, 21];
however, some investigators had a more rigid deﬁnition of
equaltoorgreaterthan1redbloodcellperHPFassigniﬁcant
hematuria [9, 22–24]. Some others have deﬁned a threshold
of 6 or more RBCs per HPF as signiﬁcant hematuria [25, 26].
An algorithmic approach to the workup of microhe-
maturia in females is shown in Figure 1.T h ep r e s e n c eo f
signiﬁcant proteinuria, red cell casts, or predominance of
dysmorphic red blood cell in the urine should prompt an
evaluation for renal parenchymal disease or referral to a
nephrologist.
If a careful history suggests a potential benign cause
for microscopic hematuria, the patients should undergo
repeat urinalysis 48 hours after cessation of the activity
(menstruation, vigorous exercise, sexual activity, or trauma).
No additional evaluation is warranted if the hematuria has
resolved. Patients with persistent hematuria require evalua-
tion. In women, urethral and vaginal examination should be
performed to exclude local causes of microscopic hematuria.
Patients with urinary tract infection should be treated
appropriately and urinalysis should be repeated six weeks
after treatment. If the hematuria resolves with treatment, no
additional evaluation is necessary. Cystoscopy as a compo-
nent of initial evaluation of microscopic hematuria in all
adult patients more than 40 years of age, and in patients less
than 40 years of age with risk factors for bladder cancer, (e.g.,
c u r r e n to rf o r m e rt o b a c c ou s e r s ;p e r s o n sw i t ho c c u p a t i o n a l
exposure in chemical, textile, or rubber industries; persons4 Advances in Urology
Positive dipstick test for heme
Microscopic evaluation of urine to confirm presence of RBCs
RBCs exist RBCs not exist
Findings in support of glomerular causes
(e.g. proteinuria, dismorphic cells, cell casts)   
Positive Negative
History of mesturation, trauma or vigorous
exercise  
Positive  Negative
Refer to 
nephrologists
Renal
ultrasonography  
Computed
tumography  
Urine cytology
Negative Positive
Cystoscopy  Low risk High risk &
suspicious cases  
Follow
Positive  Negative
Intravenous
urography 
Negative Positive
48 hours later
Urine culture
Positive  Negative
Figure 1: Algorithmic approach to microscopic hematuria in females.
with past exposure to phenacetin, cyclophosphamide, or
pelvic radiation therapy; patients with chronic urinary
tract infections or neurogenic bladder; patients with spinal
cord injury with intermittent catheterization or indwelling
catheter) [27].
One of our cases was diagnosed as having bladder tumor
almost 24 months after initial evaluations for microhema-
turia (Case 3). During this time period, she underwent
repeated cystoscopy and cytological evaluations and patho-
logicalstudiesonbiopsyspecimens;however,nothingrelated
to malignancy was found. Chow et al. also reported that 1%
ofpatientswouldrepresenttransitionalcarcinomaofurinary
bladder 20 months after initial presentation [28]. Messing et
al. found a less than 9 months brief preclinical duration of
bladder tumors for men [29].
In conclusion, microscopic hematuria in females, either
symptomatic or asymptomatic, is of extreme relevance and
deserves full evaluations; especially in elderly patients or
patients at high risk for bladder cancer.Here we highlight the
ﬁnding that only 1 of the 249 patients had true symptomaticAdvances in Urology 5
microhematuria and was found to have cancer. Patients
whose reason for microhematuria would not be diagnosed
at the initial evaluations should be followed.
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